US Stock MarketDetailed Quotes

BNOX Bionomics

Watchlist
  • 0.368
  • -0.037-9.12%
Close Nov 11 16:00 ET
  • 0.352
  • -0.016-4.29%
Post 18:25 ET
6.37MMarket Cap-310P/E (TTM)

About Bionomics Company

Bionomics Ltd. is a clinical stage biopharmaceutical company, which develops novel, allosteric ion channel modulators designed to transform the lives of patients suffering from serious central nervous system disorders with high unmet medical need. Its lead product candidate is BNC210. The company was founded in 1996 and is headquartered in Eastwood, Australia.

Company Profile

SymbolBNOX
Company NameBionomics
Issue Price12.35
Founded1996
CEODr. Spyros Papapetropoulos, PhD
MarketNASDAQ
Employees24
Securities TypeDR
ADS Ratio1.0 : 180.0
Fiscal Year Ends06-30
Address200 Greenhill Road
CityEastwood
ProvinceSouth Australia (SA)
CountryAustralia
Zip Code5063
Phone61-8-8150-7400
Websitehttp://www.bionomics.com.au

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Spyros Papapetropoulos, PhD
  • President and Chief Executive Officer
  • 919.77K
  • Timothy M. Cunningham
  • Chief Financial Officer
  • --
  • Liz Doolin
  • Vice President, Clinical Development
  • 357.03K
  • Alan Fisher
  • Chairman of the Board
  • 87.00K
  • Dr. Errol B. De Souza,PhD
  • Director
  • 3.09M
  • Dr. Jane Ryan
  • Independent Director
  • 86.72K
  • Peter Miles Davies
  • Independent Director
  • 77.00K
  • David Wilson
  • Independent Director
  • 87.00K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data